Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05063227 |
Other study ID # |
2021-06 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
October 6, 2021 |
Est. completion date |
January 4, 2023 |
Study information
Verified date |
July 2023 |
Source |
Universitätsklinikum Hamburg-Eppendorf |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
General anesthesia is a combination of hypnotic drugs and opioid analgesics. Modern general
anesthesia aims to treat nociception induced by surgical stimulation while avoiding an
overdose of opioid analgesics and reducing side-effects of opioid administration. Quality and
safety of general anesthesia are of major clinical importance and can be improved by
adjusting the opioid analgesics to the optimal individual dose needed. In the current
clinical practice, the opioid dosage is usually chosen by clinical judgment, though recently
different monitoring devices estimating the effect of nociception during unconsciousness have
become commercially available. Nevertheless, the impact of nociception-monitor-guided opioid
administration on the administered amount of opioid, postoperative short-term recovery, and
long-term outcome is inconclusive. This study aims to investigate the predictive power of
different nociception monitoring systems for the prediction of moderate to severe immediate
postoperative pain from nociception indices measured before awakening from general
anesthesia.
Description:
General anesthesia is a combination of hypnotic drugs and opioid analgesics. Modern general
anesthesia aims to treat nociception induced by surgical stimulation while avoiding an
overdose of opioid analgesics and reducing side-effects of opioid administration. Underdosing
of opioids during surgery can lead to nociception with increased sympathetic tone, elevated
levels of stress hormones, unintended patient movement due to nociception as well as
increased postoperative pain. On the other hand, overdosing of opioids can lead to negative
side effects such as nausea and vomiting, arterial hypotension, immunosuppression, prolonged
recovery times, postoperative delirium and an increase in postoperative pain by
opioid-induced-hyperalgesia. Quality and safety of general anesthesia are of major clinical
importance and can be improved by adjusting the opioid analgesics to the optimal individual
dose needed. In the current clinical practice, the opioid dosage is chosen by clinical
judgment of the attending anesthesiologist based on changes in the heart rate, blood
pressure, pupil size, lacrimation and sweating of the patient. In recent years, different
monitoring devices estimating the effect of nociception during unconsciousness have become
commercially available. These monitoring devices use several different mechanisms, such as
heart rate (HR) variability, pulse wave photoplethysmography, pupil reflex dilation, and skin
conductance measurement, and based on these signals index the nociception/analgesia balance.
Such monitoring devices should help physicians choose the right dose of opioid analgesics
during general anesthesia. Nevertheless, the impact of nociception-monitor-guided opioid
administration on the administered amount of opioid, postoperative short-term recovery, and
long-term outcome is inconclusive.
Current literature is inconclusive if the nociception monitoring devices have predictive
power to predict immediate postoperative pain after awakening from general anesthesia already
before awakening from general anesthesia.
In this prospective, double-blinded, observational clinical study the investigators aim to
evaluate the predictive power of different nociception monitoring systems for the prediction
of moderate to severe immediate postoperative pain from nociception indices measured before
awakening from general anesthesia. The nociception monitoring systems included in the study
are the Surgical Pleth Index (SPI), the Pupillary Pain Index (PPI) and the Nociception Level
(NOL) and heart rate changes as a variable used in current clinical practice to choose the
opioid dosage during general anesthesia.
The postoperative pain level will be assessed from anesthesia nurses using the Numerical
Rating Scale (NRS) who are blinded to the nociception indices measured before awakening.
For SPI monitoring there are findings suggesting that an SPI > 30 could be the 'best-fit'
optimal threshold with the highest sum of sensitivity and specificity to detect moderate to
severe pain. Nevertheless, positive and negative predictive value of SPI were still rather
low.
For PPI monitoring there are data demonstrating a moderate correlation between PPI values
before tracheal extubation and postoperative pain. Another study with pupil dilatation reflex
threshold showed only a minor correlation between pupil dilatation reflex threshold and the
intensity of immediate postoperative pain.
For NOL monitoring, on the one hand, there are data suggesting that a threshold of > 20 after
knife to skin incision has predictive power to predict moderate to severe postoperative pain.
On the other hand, the highest combined sensitivity and specificity were still rather low.
While a NOL < 10 after skin incision excluded moderate-severe postoperative pain with a
negative predictive value of 83%, the NOL during surgery and at the end of surgery did not
allow the exclusion or the prediction of moderate-severe postoperative pain.